Bruder Healthcare, a Hilco Vision Company, entered into an exclusive distribution agreement with Santen S.A. to market Eyeleve MGD in the U.S. in early 2025. The eye drop formulation was previously marketed in the U.S. as Retaine MGD. The preservative-free ophthalmic emulsion provides moisturization, lubrication, and protection for moderate-to -severe evaporative dry eye, according to Bruder.